Stiff person spectrum disorders: An illustrative case series of their phenotypic and antibody diversity

Bernardo F, Rebordão L, Rêgo A, Machado S, Passos J, Costa C, Cruz S, Pinto AN, Santos M.

J Neuroimmunol. 2020 Apr 15;341:577192. doi: 10.1016/j.jneuroim.2020.577192. Epub 2020 Feb 13.

Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies

Muñiz-Castrillo S, Ambati A, Dubois V, Vogrig A, Joubert B, Rogemond V, Picard G, Lin L, Fabien N, Mignot E, Honnorat J.

J Neurol. 2020 Jul;267(7):1906-1911. doi: 10.1007/s00415-020-09782-8. Epub 2020 Mar 9.

Possible link of genetic variants to autoimmunity in GAD-antibody-associated neurological disorders

Thaler FS, Bangol B, Biljecki M, Havla J, Schumacher AM, Kümpfel T.

J Neurol Sci. 2020 Jun 15;413:116860. doi: 10.1016/j.jns.2020.116860. Epub 2020 Apr 29.

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment

Muñoz-Lopetegi A, de Bruijn MAAM, Boukhrissi S, Bastiaansen AEM, Nagtzaam MMP, Hulsenboom ESP, Boon AJW, Neuteboom RF, de Vries JM, Sillevis Smitt PAE, Schreurs MWJ, Titulaer MJ.

Neurol Neuroimmunol Neuroinflamm. 2020 Mar 2;7(3):e696. doi: 10.1212/NXI.0000000000000696. Print 2020 May.

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?

Li TR, Zhang YD, Wang Q, Shao XQ, Li ZM, Lv RJ.

BMC Neurosci. 2020 Mar 30;21(1):13. doi: 10.1186/s12868-020-00561-9.

Clinical features and immunotherapy outcomes of anti-glutamic acid decarboxylase 65 antibody-associated neurological disorders

Chengyu L, Weixiong S, Chao C, Songyan L, Lin S, Zhong Z, Hua P, Fan J, Na C, Tao C, Jianwei W, Haitao R, Hongzhi G, Xiaoqiu S.

J Neuroimmunol. 2020 Aug 15;345:577289. doi: 10.1016/j.jneuroim.2020.577289. Epub 2020 Jun 10.

Clinical characteristics of GAD 65-associated autoimmune encephalitis

Zhu F, Shan W, Lv R, Li Z, Wang Q.

Acta Neurol Scand. 2020 Sep;142(3):281-293. doi: 10.1111/ane.13281. Epub 2020 Jun 15.

Cerebellar Ataxia Followed by Stiff Person Syndrome in a Patient with Anti-GAD Antibodies

Seneviratne SO, Buzzard KA, Cruse B, Monif M.

Case Reports Immunol. 2020 Feb 8;2020:8454532. doi: 10.1155/2020/8454532. eCollection 2020.

Neurological Syndromes Associated with Anti-GAD Antibodies

Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, Psimaras D, Alentorn A.

Int J Mol Sci. 2020 May 24;21(10):3701. doi: 10.3390/ijms21103701.

GAD antibodies in neurological disorders - insights and challenges

Graus F, Saiz A, Dalmau J.

Nat Rev Neurol. 2020 May 26. doi: 10.1038/s41582-020-0359-x. Online ahead of print.

Intranasal midazolam for treating acute respiratory crises in a woman with stiff person syndrome

Cosentino G, Romano M, Algeri M, Brighina F, Alfonsi E, Tassorelli C, Crescimanno G.

Neurol Neuroimmunol Neuroinflamm. 2020 Apr 1;7(4):e715. doi: 10.1212/NXI.0000000000000715. Print 2020 Jul.

Improvement of stiff-person syndrome symptoms in pregnancy: Case series and literature review

Esch ME, Newsome SD.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 25;7(3):e684. doi: 10.1212/NXI.0000000000000684. Print 2020 May.

Stiff Person Syndrome Masquerading as Acute Coronary Syndrome.

Sharma A, Soe MH, Singh J, Newsome SD.

J Natl Med Assoc. 2016 Autumn;108(3):169-172. doi: 10.1016/j.jnma.2016.06.005.

Stiff Person Syndrome and Type 1 Diabetes Mellitus: a Case of the Chicken or the Egg?

Rathbun JT, Imber J.

J Gen Intern Med. 2019 Feb 19. doi: 10.1007/s11606-019-04835-9. [Epub ahead of print]

A double blind, placebo-controlled study of rituximab in patients with stiff person syndrome.

Dalakas MC, Rakocevic G, Dambrosia JM, Alexopoulos H, McElroy B.

Ann Neurol. 2017 Jul 27. doi: 10.1002/ana.25002. [Epub ahead of print]